Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer
Clinical trial NCT03936933 · TERMINATED
Trial details
- NCT number
- NCT03936933
- Sponsor
- Eurofarma Laboratorios S.A.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2024-09-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.